메뉴 건너뛰기




Volumn 172, Issue 9, 2013, Pages 1149-1160

Educational paper: Decreasing the burden of cardiovascular disease in childhood cancer survivors: An update for the pediatrician

Author keywords

Cardiotoxicity; Chemotherapy; Childhood cancer survivor

Indexed keywords

ANTHRACYCLINE; ARSENIC TRIOXIDE; BEVACIZUMAB; CAPECITABINE; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; MITOMYCIN; PACLITAXEL; SORAFENIB; TRASTUZUMAB;

EID: 84892780806     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-013-1931-9     Document Type: Review
Times cited : (24)

References (101)
  • 1
    • 84892833155 scopus 로고    scopus 로고
    • Long term follow up of survivors of childhood cancer: A national clinical guideline
    • Edinburgh
    • Long term follow up of survivors of childhood cancer: A national clinical guideline. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh
    • (2007) Scottish Intercollegiate Guidelines Network (SIGN)
  • 2
    • 18244372155 scopus 로고    scopus 로고
    • Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: Implications for screening and prevention
    • Adams MJ, Lipshultz SE (2005) Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer 44:600-606
    • (2005) Pediatr Blood Cancer , vol.44 , pp. 600-606
    • Adams, M.J.1    Lipshultz, S.E.2
  • 7
    • 65549100587 scopus 로고    scopus 로고
    • Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study
    • Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC (2009) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 27:2328-2338
    • (2009) J Clin Oncol , vol.27 , pp. 2328-2338
    • Armstrong, G.T.1    Liu, Q.2    Yasui, Y.3    Neglia, J.P.4    Leisenring, W.5    Robison, L.L.6    Mertens, A.C.7
  • 8
    • 77949889809 scopus 로고    scopus 로고
    • Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer
    • Armstrong GT, Pan Z, Ness KK, Srivastava D, Robison LL (2010) Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer. J Clin Oncol 28:1224-1231
    • (2010) J Clin Oncol , vol.28 , pp. 1224-1231
    • Armstrong, G.T.1    Pan, Z.2    Ness, K.K.3    Srivastava, D.4    Robison, L.L.5
  • 11
    • 0141939058 scopus 로고    scopus 로고
    • Effect of arsenic trioxide on QT interval in patients with advanced malignancies
    • Barbey JT, Pezzullo JC, Soignet SL (2003) Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol 21:3609-3615
    • (2003) J Clin Oncol , vol.21 , pp. 3609-3615
    • Barbey, J.T.1    Pezzullo, J.C.2    Soignet, S.L.3
  • 14
    • 85044707358 scopus 로고    scopus 로고
    • Cardioprotection against the toxic effects of anthracyclines given to children with cancer: A systematic review
    • iii, ix-x
    • Bryant J, Picot J, Levitt G, Sullivan I, Baxter L, Clegg A (2007) Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Health Technol Assess 11:1-84, iii, ix-x
    • (2007) Health Technol Assess , vol.11 , pp. 1-84
    • Bryant, J.1    Picot, J.2    Levitt, G.3    Sullivan, I.4    Baxter, L.5    Clegg, A.6
  • 15
    • 0141725521 scopus 로고    scopus 로고
    • Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): Possible role in hypersensitivity reactions
    • Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique NM, Alving CR, Muggia FM (2003) Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol 14:1430-1437
    • (2003) Ann Oncol , vol.14 , pp. 1430-1437
    • Chanan-Khan, A.1    Szebeni, J.2    Savay, S.3    Liebes, L.4    Rafique, N.M.5    Alving, C.R.6    Muggia, F.M.7
  • 16
    • 68949170698 scopus 로고    scopus 로고
    • Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents
    • Chen C, Heusch A, Donner B, Janssen G, Gobel U, Schmidt KG (2009) Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents. Klin Padiatr 221:162-166
    • (2009) Klin Padiatr , vol.221 , pp. 162-166
    • Chen, C.1    Heusch, A.2    Donner, B.3    Janssen, G.4    Gobel, U.5    Schmidt, K.G.6
  • 21
    • 77957306355 scopus 로고    scopus 로고
    • Cardiotoxicity of anticancer treatments: What the cardiologist needs to know
    • Ewer MS, Ewer SM(2010) Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat Rev Cardiol 7:564-575
    • (2010) Nat Rev Cardiol , vol.7 , pp. 564-575
    • Ewer, M.S.1    Ewer, S.M.2
  • 22
    • 79957576807 scopus 로고    scopus 로고
    • The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy
    • Fallah-Rad N,Walker JR,WassefA, LytwynM, Bohonis S, Fang T, Tian G, Kirkpatrick ID, Singal PK, Krahn M, Grenier D, Jassal DS (2011) The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol 57:2263-2270
    • (2011) J Am Coll Cardiol , vol.57 , pp. 2263-2270
    • Fallah-Rad, N.1    Walker, J.R.2    Wassef, A.3    Lytwyn, M.4    Bohonis, S.5    Fang, T.6    Tian, G.7    Kirkpatrick, I.D.8    Singal, P.K.9    Krahn, M.10    Grenier, D.11    Jassal, D.S.12
  • 23
    • 0029945190 scopus 로고    scopus 로고
    • The role of corrected QT interval in the cardiologic follow-up of young patients treated with Adriamycin
    • Ferrari S, Figus E, Cagnano R, Iantorno D, Bacci G (1996) The role of corrected QT interval in the cardiologic follow-up of young patients treated with Adriamycin. J Chemother 8:232-236
    • (1996) J Chemother , vol.8 , pp. 232-236
    • Ferrari, S.1    Figus, E.2    Cagnano, R.3    Iantorno, D.4    Bacci, G.5
  • 24
    • 0036119213 scopus 로고    scopus 로고
    • Longitudinal evaluation of anthracycline cardiotoxicity by signal-averaged electrocardiography in children with cancer
    • Fukumi D, Uchikoba Y, Maeda M, Ogawa S (2002) Longitudinal evaluation of anthracycline cardiotoxicity by signal-averaged electrocardiography in children with cancer. Pediatr Int 44:134-140
    • (2002) Pediatr Int , vol.44 , pp. 134-140
    • Fukumi, D.1    Uchikoba, Y.2    Maeda, M.3    Ogawa, S.4
  • 27
    • 48249098888 scopus 로고    scopus 로고
    • Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity
    • Germanakis I, Anagnostatou N, Kalmanti M (2008) Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity. Pediatr Blood Cancer 51:327-333
    • (2008) Pediatr Blood Cancer , vol.51 , pp. 327-333
    • Germanakis, I.1    Anagnostatou, N.2    Kalmanti, M.3
  • 28
    • 33644685056 scopus 로고    scopus 로고
    • Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines
    • Germanakis I, Kalmanti M, Parthenakis F, Nikitovic D, Stiakaki E, Patrianakos A, Vardas PE (2006) Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int J Cardiol 108:212-215
    • (2006) Int J Cardiol , vol.108 , pp. 212-215
    • Germanakis, I.1    Kalmanti, M.2    Parthenakis, F.3    Nikitovic, D.4    Stiakaki, E.5    Patrianakos, A.6    Vardas, P.E.7
  • 29
    • 0022263591 scopus 로고
    • Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen
    • Gianni L, Zweier JL, Levy A, Myers CE (1985) Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen. J Biol Chem 260:6820-6826
    • (1985) J Biol Chem , vol.260 , pp. 6820-6826
    • Gianni, L.1    Zweier, J.L.2    Levy, A.3    Myers, C.E.4
  • 32
    • 0022806838 scopus 로고
    • Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor
    • Goldberg MA, Antin JH, Guinan EC, Rappeport JM (1986) Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 68:1114-1118
    • (1986) Blood , vol.68 , pp. 1114-1118
    • Goldberg, M.A.1    Antin, J.H.2    Guinan, E.C.3    Rappeport, J.M.4
  • 35
    • 0031660433 scopus 로고    scopus 로고
    • Epidemiology of anthracycline cardiotoxicity in children and adults
    • Grenier MA, Lipshultz SE (1998) Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 25:72-85
    • (1998) Semin Oncol , vol.25 , pp. 72-85
    • Grenier, M.A.1    Lipshultz, S.E.2
  • 36
    • 1842865962 scopus 로고    scopus 로고
    • Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy
    • Gupta M, Thaler HT, Friedman D, Steinherz L (2002) Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy. Pediatr Hematol Oncol 19:533-542
    • (2002) Pediatr Hematol Oncol , vol.19 , pp. 533-542
    • Gupta, M.1    Thaler, H.T.2    Friedman, D.3    Steinherz, L.4
  • 37
    • 0027223298 scopus 로고
    • Cardiac disease following treatment of Hodgkin's disease in children and adolescents
    • Hancock SL, Donaldson SS, Hoppe RT (1993) Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1208-1215
    • (1993) J Clin Oncol , vol.11 , pp. 1208-1215
    • Hancock, S.L.1    Donaldson, S.S.2    Hoppe, R.T.3
  • 38
    • 0034964104 scopus 로고    scopus 로고
    • Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer
    • Hayakawa H, Komada Y, Hirayama M, Hori H, Ito M, Sakurai M (2001) Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. Med Pediatr Oncol 37:4-9
    • (2001) Med Pediatr Oncol , vol.37 , pp. 4-9
    • Hayakawa, H.1    Komada, Y.2    Hirayama, M.3    Hori, H.4    Ito, M.5    Sakurai, M.6
  • 42
    • 0344667638 scopus 로고    scopus 로고
    • Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy
    • Hull MC, Morris CG, Pepine CJ, Mendenhall NP (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290:2831-2837
    • (2003) JAMA , vol.290 , pp. 2831-2837
    • Hull, M.C.1    Morris, C.G.2    Pepine, C.J.3    Mendenhall, N.P.4
  • 45
    • 0035155497 scopus 로고    scopus 로고
    • Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study
    • Kremer LC, van Dalen EC, Offringa M, Ottenkamp J, Voute PA (2001) Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 19:191-196
    • (2001) J Clin Oncol , vol.19 , pp. 191-196
    • Kremer, L.C.1    Van Dalen, E.C.2    Offringa, M.3    Ottenkamp, J.4    Voute, P.A.5
  • 46
    • 0035990041 scopus 로고    scopus 로고
    • Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: A systematic review
    • Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voute PA (2002) Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13:819-829
    • (2002) Ann Oncol , vol.13 , pp. 819-829
    • Kremer, L.C.1    Van Der Pal, H.J.2    Offringa, M.3    Van Dalen, E.C.4    Voute, P.A.5
  • 47
    • 0030904457 scopus 로고    scopus 로고
    • Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience
    • Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE (1997) Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 15:1544-1552
    • (1997) J Clin Oncol , vol.15 , pp. 1544-1552
    • Krischer, J.P.1    Epstein, S.2    Cuthbertson, D.D.3    Goorin, A.M.4    Epstein, M.L.5    Lipshultz, S.E.6
  • 48
    • 0025257186 scopus 로고
    • Cardiac involvement in bone marrow transplantation: Serial changes in left ventricular size, mass and performance
    • Kupari M, Volin L, Suokas A, Hekali P, Ruutu T (1990) Cardiac involvement in bone marrow transplantation: serial changes in left ventricular size, mass and performance. J Intern Med 227:259-266
    • (1990) J Intern Med , vol.227 , pp. 259-266
    • Kupari, M.1    Volin, L.2    Suokas, A.3    Hekali, P.4    Ruutu, T.5
  • 49
    • 0025231510 scopus 로고
    • Cardiac involvement in bone marrow transplantation: Electrocardiographic changes, arrhythmias, heart failure and autopsy findings
    • Kupari M, Volin L, Suokas A, Timonen T, Hekali P, Ruutu T (1990) Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant 5:91-98
    • (1990) Bone Marrow Transplant , vol.5 , pp. 91-98
    • Kupari, M.1    Volin, L.2    Suokas, A.3    Timonen, T.4    Hekali, P.5    Ruutu, T.6
  • 51
    • 33846934456 scopus 로고    scopus 로고
    • Mortality experiences among 15+ year survivors of childhood and adolescent cancers
    • Lawless SC, Verma P, Green DM, Mahoney MC (2007) Mortality experiences among 15+ year survivors of childhood and adolescent cancers. Pediatr Blood Cancer 48:333-338
    • (2007) Pediatr Blood Cancer , vol.48 , pp. 333-338
    • Lawless, S.C.1    Verma, P.2    Green, D.M.3    Mahoney, M.C.4
  • 52
    • 77950464739 scopus 로고    scopus 로고
    • Cardiotoxicity after childhood cancer: Beginning with the end in mind
    • Lipshultz SE, Adams MJ (2010) Cardiotoxicity after childhood cancer: beginning with the end in mind. J Clin Oncol 28:1276-1281
    • (2010) J Clin Oncol , vol.28 , pp. 1276-1281
    • Lipshultz, S.E.1    Adams, M.J.2
  • 53
    • 41149115636 scopus 로고    scopus 로고
    • Anthracycline associated cardiotoxicity in survivors of childhood cancer
    • Lipshultz SE, Alvarez JA, Scully RE (2008) Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 94:525-533
    • (2008) Heart , vol.94 , pp. 525-533
    • Lipshultz, S.E.1    Alvarez, J.A.2    Scully, R.E.3
  • 56
    • 18444416815 scopus 로고    scopus 로고
    • Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia
    • Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD (2005) Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2629-2636
    • (2005) J Clin Oncol , vol.23 , pp. 2629-2636
    • Lipshultz, S.E.1    Lipsitz, S.R.2    Sallan, S.E.3    Dalton, V.M.4    Mone, S.M.5    Gelber, R.D.6    Colan, S.D.7
  • 58
    • 77952533323 scopus 로고    scopus 로고
    • Tomorrow's targeted therapies in breast cancer patients: What is the risk for increased radiationinduced cardiac toxicity?
    • Magne N, Chargari C, MacDermed D, Conforti R, Vedrine L, Spano JP, Khayat D (2010) Tomorrow's targeted therapies in breast cancer patients: what is the risk for increased radiationinduced cardiac toxicity? Crit Rev Oncol Hematol 76:186-195
    • (2010) Crit Rev Oncol Hematol , vol.76 , pp. 186-195
    • Magne, N.1    Chargari, C.2    MacDermed, D.3    Conforti, R.4    Vedrine, L.5    Spano, J.P.6    Khayat, D.7
  • 61
    • 53749090347 scopus 로고    scopus 로고
    • The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: A review of the literature
    • Mavinkurve-Groothuis AM, Kapusta L, Nir A, Groot-Loonen J (2008) The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature. Pediatr Hematol Oncol 25:655-664
    • (2008) Pediatr Hematol Oncol , vol.25 , pp. 655-664
    • Mavinkurve-Groothuis, A.M.1    Kapusta, L.2    Nir, A.3    Groot-Loonen, J.4
  • 66
    • 0028068536 scopus 로고
    • Mechanism of 'inappropriate' sinus tachycardia. Role of sympathovagal balance
    • Morillo CA, Klein GJ, Thakur RK, Li H, Zardini M, Yee R (1994) Mechanism of 'inappropriate' sinus tachycardia. Role of sympathovagal balance. Circulation 90:873-877
    • (1994) Circulation , vol.90 , pp. 873-877
    • Morillo, C.A.1    Klein, G.J.2    Thakur, R.K.3    Li, H.4    Zardini, M.5    Yee, R.6
  • 67
    • 78649848061 scopus 로고    scopus 로고
    • Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation
    • Motoki N, Shimizu T, Akazawa Y, Saito S, TanakaM, Yanagisawa R, Motoki H, Nakazawa Y, Sakashita K, Iwasaki Y, Shiohara M, Koike K (2010) Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Transplant 14:986-992
    • (2010) Pediatr Transplant , vol.14 , pp. 986-992
    • Motoki, N.1    Shimizu, T.2    Akazawa, Y.3    Saito, S.4    Tanakam, Y.R.5    Motoki, H.6    Nakazawa, Y.7    Sakashita, K.8    Iwasaki, Y.9    Shiohara, M.10    Koike, K.11
  • 69
    • 2342468821 scopus 로고    scopus 로고
    • Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation
    • Nakamae H, Hino M, Akahori M, Terada Y, Yamane T, Ohta K, Hayashi T, Tsumura K (2004) Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation. Am J Hematol 76:1-7
    • (2004) Am J Hematol , vol.76 , pp. 1-7
    • Nakamae, H.1    Hino, M.2    Akahori, M.3    Terada, Y.4    Yamane, T.5    Ohta, K.6    Hayashi, T.7    Tsumura, K.8
  • 72
    • 0034091608 scopus 로고    scopus 로고
    • Cardiotoxicity of chemotherapeutic agents: Incidence, treatment and prevention
    • Pai VB, Nahata MC (2000) Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 22:263-302
    • (2000) Drug Saf , vol.22 , pp. 263-302
    • Pai, V.B.1    Nahata, M.C.2
  • 73
    • 84863000662 scopus 로고    scopus 로고
    • Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction
    • Poterucha JT, Kutty S, Lindquist RK, Li L, Eidem BW (2012) Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr 25:733-740
    • (2012) J Am Soc Echocardiogr , vol.25 , pp. 733-740
    • Poterucha, J.T.1    Kutty, S.2    Lindquist, R.K.3    Li, L.4    Eidem, B.W.5
  • 74
    • 70350767248 scopus 로고    scopus 로고
    • Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
    • Rajic V, Aplenc R, Debeljak M, Prestor VV, Karas-Kuzelicki N, Mlinaric-Rascan I, Jazbec J (2009) Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood. Leuk Lymphoma 50:1693-1698
    • (2009) Leuk Lymphoma , vol.50 , pp. 1693-1698
    • Rajic, V.1    Aplenc, R.2    Debeljak, M.3    Prestor, V.V.4    Karas-Kuzelicki, N.5    Mlinaric-Rascan, I.6    Jazbec, J.7
  • 75
    • 76749148528 scopus 로고    scopus 로고
    • Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2 or less for acute lymphoblastic leukemia
    • Rathe M, Carlsen NL, Oxhoj H, Nielsen G (2010) Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2 or less for acute lymphoblastic leukemia. Pediatr Blood Cancer 54:444-448
    • (2010) Pediatr Blood Cancer , vol.54 , pp. 444-448
    • Rathe, M.1    Carlsen, N.L.2    Oxhoj, H.3    Nielsen, G.4
  • 77
    • 79951967483 scopus 로고    scopus 로고
    • Isovolumic acceleration at rest and during exercise in children normal values for the left ventricle and first noninvasive demonstration of exercise-induced force-frequency relationships
    • Roche SL, Vogel M, Pitkanen O, Grant B, Slorach C, Fackoury C, Stephens D, Smallhorn J, Benson LN, Kantor PF, Redington AN (2011) Isovolumic acceleration at rest and during exercise in children normal values for the left ventricle and first noninvasive demonstration of exercise-induced force-frequency relationships. J Am Coll Cardiol 57:1100-1107
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1100-1107
    • Roche, S.L.1    Vogel, M.2    Pitkanen, O.3    Grant, B.4    Slorach, C.5    Fackoury, C.6    Stephens, D.7    Smallhorn, J.8    Benson, L.N.9    Kantor, P.F.10    Redington, A.N.11
  • 78
    • 33846955073 scopus 로고    scopus 로고
    • Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A populationbased study
    • Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Moller H (2007) Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a populationbased study. BMC Cancer 7:9
    • (2007) BMC Cancer , vol.7 , pp. 9
    • Roychoudhuri, R.1    Robinson, D.2    Putcha, V.3    Cuzick, J.4    Darby, S.5    Moller, H.6
  • 81
    • 0037096826 scopus 로고    scopus 로고
    • 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: Clinical practice guidelines of the American Society of Clinical Oncology
    • Schuchter LM, Hensley ML, Meropol NJ, Winer EP (2002) 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 20:2895-2903
    • (2002) J Clin Oncol , vol.20 , pp. 2895-2903
    • Schuchter, L.M.1    Hensley, M.L.2    Meropol, N.J.3    Winer, E.P.4
  • 83
    • 80051904456 scopus 로고    scopus 로고
    • The use of liposomal anthracycline analogues for childhood malignancies: A systematic review
    • Sieswerda E, Kremer LC, Caron HN, van Dalen EC (2011) The use of liposomal anthracycline analogues for childhood malignancies: a systematic review. Eur J Cancer 47:2000-2008
    • (2011) Eur J Cancer , vol.47 , pp. 2000-2008
    • Sieswerda, E.1    Kremer, L.C.2    Caron, H.N.3    Van Dalen, E.C.4
  • 85
    • 77950106489 scopus 로고    scopus 로고
    • Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer
    • Sieswerda E, van Dalen EC, Postma A, Cheuk DK, Caron HN, Kremer LC (2011) Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Cochrane Database Syst Rev: CD008011
    • (2011) Cochrane Database Syst Rev
    • Sieswerda, E.1    Van Dalen, E.C.2    Postma, A.3    Cheuk, D.K.4    Caron, H.N.5    Kremer, L.C.6
  • 88
    • 24744439974 scopus 로고    scopus 로고
    • Plasma concentrations of NTpro- BNP and cardiac troponin-I in relation to doxorubicin- induced cardiomyopathy and cardiac function in childhood malignancy
    • Soker M, Kervancioglu M (2005) Plasma concentrations of NTpro- BNP and cardiac troponin-I in relation to doxorubicin- induced cardiomyopathy and cardiac function in childhood malignancy. Saudi Med J 26:1197-1202
    • (2005) Saudi Med J , vol.26 , pp. 1197-1202
    • Soker, M.1    Kervancioglu, M.2
  • 89
    • 0025917514 scopus 로고
    • Delayed cardiac toxicity from anthracycline therapy
    • Steinherz L, Steinherz P (1991) Delayed cardiac toxicity from anthracycline therapy. Pediatrician 18:49-52
    • (1991) Pediatrician , vol.18 , pp. 49-52
    • Steinherz, L.1    Steinherz, P.2
  • 90
    • 0029002097 scopus 로고
    • Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: A series of 15 patients
    • Steinherz LJ, Steinherz PG, Tan C (1995) Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol 24:352-361
    • (1995) Med Pediatr Oncol , vol.24 , pp. 352-361
    • Steinherz, L.J.1    Steinherz, P.G.2    Tan, C.3
  • 93
    • 0742269397 scopus 로고    scopus 로고
    • The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: Expert panel review
    • Swain SM, Vici P (2004) The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review. J Cancer Res Clin Oncol 130:1-7
    • (2004) J Cancer Res Clin Oncol , vol.130 , pp. 1-7
    • Swain, S.M.1    Vici, P.2
  • 94
    • 0026785018 scopus 로고
    • Ventricular late potentials: Another expression of cardiotoxicity of cytostatic drugs in children?
    • Tamminga RY, Bink-Boelkens MT, Kievit J (1992) Ventricular late potentials: another expression of cardiotoxicity of cytostatic drugs in children? Int J Cardiol 36:283-288
    • (1992) Int J Cardiol , vol.36 , pp. 283-288
    • Tamminga, R.Y.1    Bink-Boelkens, M.T.2    Kievit, J.3
  • 95
    • 33845328492 scopus 로고    scopus 로고
    • Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up study
    • van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC (2006) Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer 42:3191-3198
    • (2006) Eur J Cancer , vol.42 , pp. 3191-3198
    • Van Dalen, E.C.1    Van Der Pal, H.J.2    Kok, W.E.3    Caron, H.N.4    Kremer, L.C.5
  • 99
    • 0026029483 scopus 로고
    • Severe and fatal anthracycline cardiotoxicity at cumulative doses below 400 mg/m2: Evidence for enhanced toxicity with multiagent chemotherapy
    • Watts RG (1991) Severe and fatal anthracycline cardiotoxicity at cumulative doses below 400 mg/m2: evidence for enhanced toxicity with multiagent chemotherapy. Am J Hematol 36:217-218
    • (1991) Am J Hematol , vol.36 , pp. 217-218
    • Watts, R.G.1
  • 101


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.